Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
EBITDAOperating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HUTCHMED (China) (HCM) EBITDA: 2014-2024

Historic EBITDA for HUTCHMED (China) (HCM) over the last 11 years, with Dec 2024 value amounting to -$2.6 million.

  • HUTCHMED (China)'s EBITDA rose 42.42% to -$5.5 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$25.4 million, marking a year-over-year increase of 90.65%. This contributed to the annual value of -$2.6 million for FY2024, which is 114.00% down from last year.
  • HUTCHMED (China)'s EBITDA amounted to -$2.6 million in FY2024, which was down 114.00% from $18.4 million recorded in FY2023.
  • Over the past 5 years, HUTCHMED (China)'s EBITDA peaked at $18.4 million during FY2023, and registered a low of -$328.3 million during FY2021.
  • Over the past 3 years, HUTCHMED (China)'s median EBITDA value was -$1.9 million (recorded in 2022), while the average stood at $4.6 million.
  • Its EBITDA has fluctuated over the past 5 years, first crashed by 7,433.42% in 2021, then soared by 1,065.58% in 2023.
  • HUTCHMED (China)'s EBITDA (Yearly) stood at $4.5 million in 2020, then crashed by 7,433.42% to -$328.3 million in 2021, then skyrocketed by 99.42% to -$1.9 million in 2022, then soared by 1,065.58% to $18.4 million in 2023, then crashed by 114.00% to -$2.6 million in 2024.